| 摘要 |
chemical-pharmaceutical industry. SUBSTANCE: method involves at least desogestrel or compound Org 30659 (17-alpha--17-hydroxy-11-methylene-19-norpregna-4,15-diene-20-in-3-one) taken in the amount from about 0,005 to 1,0 weight % in each pharmaceutical dosing unit where steroid agent and if necessary pharmaceutically acceptable filling agents are mixed with water and granulated. Invention provides prevention of components aggregation. EFFECT: improved method of preparing. 7 cl, 3 tbl |
